however still relatively modest by ...

however still relatively modest by international standards, the Netherlands' biotechnology industry has made impressive gains in fresh years and now provides investors with a compelling alternative to more established European "heavyweights" as it was as Scandinavia, Switzerland, and the United Kingdom.
Starting with barely a handful of biotech companies in the 1980 the Netherlands' biotech community has mushroomed to 138 entrepreneurial firms specializing in areas like as agri-foods, biologicals, kindred transfusion technology, cardiovascular disease, confined apartment growth and ...